Figure 2
Figure 2. DNGR-1+ CD103+ CD11b− DCs are found in mouse nonlymphoid tissues. (A) CD11c+ MHCII+ CD45+ live kidney cells from Batf3-sufficient mice (B6; top left panel) or Batf3−/− mice (bottom left panel) were analyzed as in Figure 1 for the expression of CD103 versus CD11b. For the Batf3+/+ mice, 2 populations were defined: gate A, CD103+, CD11b−; and gate B, CD103−, CD11b+. For the Batf3−/− mice, only 1 DC gate was defined encompassing gates A and B. Cells within these gates were analyzed for staining with anti–DNGR-1 (black) or an isotype-matched control antibody (grey). (B) CD11c+ MHCII+ CD45+ autolow live lung cells were analyzed as described for the kidney. Numbers indicate percentage of cells in each of the indicated gates. Arrows indicate gating strategy. (A-B) Data are representative of 2 independent experiments.

DNGR-1+ CD103+ CD11b DCs are found in mouse nonlymphoid tissues. (A) CD11c+ MHCII+ CD45+ live kidney cells from Batf3-sufficient mice (B6; top left panel) or Batf3−/− mice (bottom left panel) were analyzed as in Figure 1 for the expression of CD103 versus CD11b. For the Batf3+/+ mice, 2 populations were defined: gate A, CD103+, CD11b; and gate B, CD103, CD11b+. For the Batf3−/− mice, only 1 DC gate was defined encompassing gates A and B. Cells within these gates were analyzed for staining with anti–DNGR-1 (black) or an isotype-matched control antibody (grey). (B) CD11c+ MHCII+ CD45+ autolow live lung cells were analyzed as described for the kidney. Numbers indicate percentage of cells in each of the indicated gates. Arrows indicate gating strategy. (A-B) Data are representative of 2 independent experiments.

Close Modal

or Create an Account

Close Modal
Close Modal